These findings suggest that Vδ1−Vδ2−Vγ9− γδ T cells upregulated by IFN-β play a protective role against MS and that Vδ2+Vγ9+ γδ T cells may not play a major role in the treatment effects of IFN-β. The gene discussed is IFNB1; the disease is myeloid sarcoma.